2022 ASCO 指南:脑转移瘤的放射治疗

2022-05-13 美国临床肿瘤学会 Journal of Clinical Oncology

美国放射肿瘤学会 (ASTRO) 制定了脑转移瘤放射治疗指南。

中文标题:

2022 ASCO 指南:脑转移瘤的放射治疗

英文标题:

Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline

发布机构:

美国临床肿瘤学会

发布日期:

2022-05-13

简要介绍:

美国放射肿瘤学会 (ASTRO) 制定了脑转移瘤放射治疗指南。

相关资料下载:
[AttachmentFileName(sort=1, fileName=jco.22.00333.pdf)] GetToolGuiderByIdResponse(projectId=1, id=a86a51c002a8882f, title=2022 ASCO 指南:脑转移瘤的放射治疗, enTitle=Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline, guiderFrom= Journal of Clinical Oncology, authorId=0, author=, summary=美国放射肿瘤学会 (ASTRO) 制定了脑转移瘤放射治疗指南。, cover=https://img.medsci.cn/20220629/1656491032254_1608702.jpg, journalId=0, articlesId=null, associationId=8, associationName=美国临床肿瘤学会, associationIntro=美国临床肿瘤学会(ASCO,American Society of Clinical Oncology)是一个成立于1964年的非营利性组织,总目标是改善肿瘤的监护与预防。目前已有27000名肿瘤科医师加入了ASCO,分属各个肿瘤专科和亚专科。会员包括在肿瘤治疗各个层次的医师和卫生保健专业人员。ASCO由一个有19名成员的当选董事会管理,该学会的大部分业务是由志愿为学会项目花费时间和出力的ASCO会员组成的各种委员会处理的。患者支持团体的领导也经常活跃于ASCO委员会中。目前有22个由ASCO的全职人员管理和支持的委员会。, copyright=0, guiderPublishedTime=Fri May 13 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p>美国放射肿瘤学会 (ASTRO) 制定了脑转移瘤放射治疗指南。</p>, tagList=[TagDto(tagId=6811, tagName=放射治疗), TagDto(tagId=10028, tagName=脑转移瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3404, appHits=78, showAppHits=0, pcHits=336, showPcHits=3325, likes=0, shares=13, comments=2, approvalStatus=1, publishedTime=Sun Jul 03 16:21:00 CST 2022, publishedTimeString=2022-05-13, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Wed Jun 29 16:25:21 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Sat Jan 06 22:35:37 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=jco.22.00333.pdf)])
jco.22.00333.pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1232081, encodeId=59c512320818d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60445479842, createdName=ms2000000529313829, createdTime=Tue Jul 12 20:53:57 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230318, encodeId=398e123031823, content=学习了,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/0c6eb4f5fee8448087495d56e0d2ae29/a6db9aa5bc1e46fca976ef34024b8bd1.jpg, createdBy=af7a5463863, createdName=鹅不吃草, createdTime=Sun Jul 03 17:24:16 CST 2022, time=2022-07-03, status=1, ipAttribution=)]
    2022-07-12 ms2000000529313829

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1232081, encodeId=59c512320818d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60445479842, createdName=ms2000000529313829, createdTime=Tue Jul 12 20:53:57 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230318, encodeId=398e123031823, content=学习了,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210811/0c6eb4f5fee8448087495d56e0d2ae29/a6db9aa5bc1e46fca976ef34024b8bd1.jpg, createdBy=af7a5463863, createdName=鹅不吃草, createdTime=Sun Jul 03 17:24:16 CST 2022, time=2022-07-03, status=1, ipAttribution=)]
    2022-07-03 鹅不吃草

    学习了,谢谢

    0